Search

Derek S Welsbie

from Rancho Santa Fe, CA
Age ~49
Get Report
Also known as:
Derek Stuart Welsbie
Related to:
Charles M Noll, 71Joanna Granados, 43Kristi M Chapralis, 47Susan A Welsbie, 41R Welsbie, 44Andrew G Chapralis, 85George C Chapralis, 50Deidra A Cooper, 52Margo Chapralis, 75Tula G ChapralisEileen S Welsbie, 78
Connected to:
Abigail Welsch, 32Calli R Welsch, 37Dora J Welsch, 85Elaine S Welsch, 51Eleanor M Welsch, 87Elliott R Welsch, 61Guy R Welsch, 73Kay S Welsch, 89Kimberlee L Welsch, 58Lauren A Welsch, 34

Derek Welsbie Phones & Addresses

  • Rancho Santa Fe, CA
  • 8538 Hill Spring Dr, Lutherville Timonium, MD 21093
  • 8113 Bellona Ave, Towson, MD 21204
  • Baltimore, MD
  • 11264 Jamaica St, Cypress, CA 90630
  • 18420 Lemarsh St, Northridge, CA 91325
  • Encino, CA
  • Los Angeles, CA

Work

Company: Baltimore Office Address: 600 N Wolfe St Suite 100, Baltimore, MD 21287 Phones: (410) 955-6230

Education

School / High School: D Geffen Sch Of Med-Ucla 2001

Languages

English

Specialities

Ophthalmology

Professional Records

Medicine Doctors

Derek Welsbie Photo 1

Dr. Derek S Welsbie, Baltimore MD - MD (Doctor of Medicine)

View page
Specialties:
Ophthalmology
Address:
Baltimore Office
600 N Wolfe St Suite 100, Baltimore, MD 21287
(410) 955-6230 (Phone)
Languages:
English
Hospitals:
Baltimore Office
600 N Wolfe St Suite 100, Baltimore, MD 21287

Howard County General Hospital
5755 Cedar Lane, Columbia, MD 21044

Johns Hopkins Bayview Medical Center
4940 Eastern Avenue, Baltimore, MD 21224

The Johns Hopkins Hospital
1800 Orleans Street, Baltimore, MD 21287
Education:
Medical School
D Geffen Sch Of Med-Ucla
Graduated: 2001
Derek Welsbie Photo 2

Derek S. Welsbie

View page
Specialties:
Ophthalmology
Work:
Wilmer Eye Institute
1800 Orleans St, Baltimore, MD 21287
(410) 955-5080 (phone), (410) 955-0468 (fax)
Education:
Medical School
University of California, Los Angeles David Geffen School of Medicine
Graduated: 2006
Procedures:
Ophthalmological Exam
Lens and Cataract Procedures
Conditions:
Cataract
Glaucoma
Keratitis
Primary Angle-Closure Glaucoma
Languages:
English
Description:
Dr. Welsbie graduated from the University of California, Los Angeles David Geffen School of Medicine in 2006. He works in Baltimore, MD and specializes in Ophthalmology. Dr. Welsbie is affiliated with Howard County General Hospital, Johns Hopkins Bayview Medical Center and The Johns Hopkins Hospital.
Derek Welsbie Photo 3

Derek Welsbie, Baltimore MD

Work:
The Johns Hopkins Hospital
600 N Wolfe St, Baltimore, MD 21287

Business Records

Name / Title
Company / Classification
Phones & Addresses
Derek S. Welsbie
Ophthalmology
Wilmar Eye Institute
Specialty Hospital
600 N Wolfe St, Baltimore, MD 21287
(410) 955-5080

Publications

Us Patents

Methods And Materials For Assessing Prostate Cancer Therapies And Compounds

View page
US Patent:
7718684, May 18, 2010
Filed:
Feb 23, 2005
Appl. No.:
10/590445
Inventors:
Michael E. Jung - Los Angeles CA, US
Samedy Ouk - Los Angeles CA, US
Charles L. Sawyers - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Derek Welsbie - Northridge CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01N 43/50
C07D 293/00
C07D 409/00
US Classification:
514385, 514396, 514397, 514398, 514520, 514522, 558413, 558423, 548100, 5483201, 5483211, 564154, 564155
Abstract:
A modest (2-5 fold) increase in androgen receptor (AR) mRNA is the only expression change consistently associated with developing resistance to antiandrogen therapy. Increased levels of AR confer resistance to anti-androgens by amplifying signal output from low levels of residual ligand and altering the normal response to antagonists. This invention provides cell based assays for use in the examination of new therapeutic modalities and provides for the design of novel antiandrogen compounds.

Methods And Materials For Assessing Prostate Cancer Therapies

View page
US Patent:
8034548, Oct 11, 2011
Filed:
Dec 16, 2004
Appl. No.:
10/583280
Inventors:
Charles L. Sawyers - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Derek S. Welsbie - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12Q 1/00
US Classification:
435 4
Abstract:
Using microarray-based profiling of isogenic prostate cancer xenograft models, we found that a modest (2-5 fold) increase in androgen receptor (AR) mRNA was the only expression change consistently associated with developing resistance to antiandrogen therapy. Increased levels of AR confer resistance to anti-androgens by amplifying signal output from low levels of residual ligand and altering the normal response to antagonists. This invention provides cell based assays for use in the examination of new therapeutic modalities and provides insight toward the design of novel antiandrogens.

Diarylhydantoin Compounds

View page
US Patent:
20070004753, Jan 4, 2007
Filed:
May 15, 2006
Appl. No.:
11/433829
Inventors:
Charles Sawyers - New York NY, US
Michael Jung - Los Angeles CA, US
Charlie Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/496
A61K 31/4166
C07D 403/02
US Classification:
514254050, 514389000, 548317100, 548324500, 544370000
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds

View page
US Patent:
20100172975, Jul 8, 2010
Filed:
Feb 18, 2010
Appl. No.:
12/708523
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Los Angeles CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - Rosemead CA, US
John Wongvipat - Arcadia CA, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166
A61K 31/4184
A61K 9/52
A61K 9/22
A61P 17/10
A61P 17/14
A61P 13/08
A61P 35/00
US Classification:
424457, 514387, 514386, 424468
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Diarylhydantoin Compounds

View page
US Patent:
20100210665, Aug 19, 2010
Filed:
Feb 18, 2010
Appl. No.:
12/708531
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/497
C07D 233/86
A61K 31/4166
C07D 401/04
A61K 31/4439
C07D 233/84
C07D 233/76
C07D 471/10
A61K 31/438
C07D 233/88
A61K 31/4164
C07D 241/04
A61P 35/00
US Classification:
51425405, 5483167, 514391, 5483014, 5462741, 514341, 546 20, 514278, 5483215, 514390, 544230
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds

View page
US Patent:
20120295944, Nov 22, 2012
Filed:
Apr 17, 2012
Appl. No.:
13/448964
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Los Angeles CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - Rosemead CA, US
John Wongvipat - Arcadia CA, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4184
A61P 35/00
A61K 31/4166
US Classification:
514391
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.

Diarylhydantoin Compounds

View page
US Patent:
20130034501, Feb 7, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/619280
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 233/02
C07D 235/02
A61P 35/00
A61K 31/496
C12Q 1/02
A61K 49/00
A61K 31/4166
C07D 403/10
US Classification:
424 92, 5483211, 514391, 5483014, 544370, 51425405, 435 29
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone lefiactory prostate cancer.

Diarylhydantoin Compounds

View page
US Patent:
20230109968, Apr 13, 2023
Filed:
Jul 13, 2022
Appl. No.:
17/863841
Inventors:
- Oakland CA, US
Michael JUNG - Los Angeles CA, US
Charlie D. CHEN - Shanghai, CN
Samedy OUK - San Diego CA, US
Derek WELSBIE - Lutherville-Timonium MD, US
Chris TRAN - New York NY, US
John WONGVIPAT - New York NY, US
Dongwon YOO - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 235/02
C07D 233/70
C07D 233/74
C07D 471/10
C07D 233/86
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Control profile
Derek S Welsbie from Rancho Santa Fe, CA, age ~49 Get Report